Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Arthur Tallis"'
Autor:
William A. Marston, Robert S. Kirsner, Arthur Tallis, Jason R. Hanft, Jodi Walters, Alik Farber, Shawn Cazzell, Anthony Comerota, John Fish, Robert Frykberg, Ian Gordon, Jason Hanft, Robert Kirsner, Aksone Nouvong, Jessica O'Connell, Robert Snyder, Dean Vayser
Publikováno v:
Journal of Vascular Surgery: Venous and Lymphatic Disorders. 8:1031-1040.e1
Background Limb compression is a key component of protocols used to heal venous leg ulcers (VLUs). A novel ambulatory pneumatic compression device was tested in comparison with multilayered bandage (MLB) compression systems for the treatment of VLUs
Autor:
Alexander M. Reyzelman, J Arroyo-Rivera, Arthur Tallis, B C Stouch, L Warren, Shawn Cazzell, Robert G. Frykberg, Thomas W. Gilbert, F Saba
Publikováno v:
Journal of wound care. 25(Sup7)
Objective: The objective of this prospective, multicentre clinical study is to assess the application of MatriStem MicroMatrix (MSMM) and MatriStem Wound Matrix (MSWM) (porcine urinary bladder derived extracellular matrix) compared with Dermagraft (D
Autor:
Curtis Waycaster, Travis Motley, Robert P. Wunderlich, Arthur Tallis, Jaime E. Dickerson, Herbert B. Slade
Publikováno v:
Clinical Therapeutics. 35:1805-1820
BackgroundDespite significant advances, the treatment of diabetic foot ulcers (DFUs) remains a major therapeutic challenge for clinicians, surgeons, and other health care professionals. There is an urgent need for new strategies with clinically effec
Publikováno v:
International Wound Journal. 12:53-58
Patients with severe acute and chronic lower extremity wounds often present a significant challenge in terms of limb salvage. In addition to control of infection, assuring adequate perfusion and providing standard wound care, advanced modalities are
Publikováno v:
Journal of the American Podiatric Medical Association. 103:67-72
Heparin is an anticoagulant commonly used to treat and prevent deep venous thrombosis. Heparin-induced thrombocytopenia and possible thrombosis are serious complications associated with its use. This can occasionally complicate treatment of patients
Autor:
Robert J, Snyder, Kenneth, Shimozaki, Arthur, Tallis, Michael, Kerzner, Alexander, Reyzelman, Dimitrios, Lintzeris, Desmond, Bell, Randi L, Rutan, Barry, Rosenblum
Publikováno v:
Wounds : a compendium of clinical research and practice. 28(3)
Delayed closure of foot ulcers is a primary factor leading to lower extremity amputation in patients with diabetes, creating great demand for products or therapies to accelerate the rate of wound closure in this population. This study (ClinicalTrials
Autor:
Wyatt G. Payne, Soma Wali, Roy Kroeker, Robert L. Engler, William A. Marston, Cyaandi Dove, Peter A. Blume, Robert S. Kirsner, Vickie R. Driver, Lois A. Chandler, Arthur Tallis, Barbara K. Sosnowski
Publikováno v:
Wound Repair and Regeneration. 19:302-308
We assessed the safety and efficacy of Formulated Collagen Gel (FCG) alone and with Ad5PDGF-B (GAM501) compared with Standard of Care (SOC) in patients with 1.5-10.0 cm(2) chronic diabetic neuropathic foot ulcers that healed
Autor:
Lois A. Chandler, Glenn F. Pierce, Arthur Tallis, Laurie Phillips, David W. Mozingo, Barbara K. Sosnowski, V. Tracy Marshall, Gerit Mulder
Publikováno v:
Wound Repair and Regeneration. 17:772-779
The results from a Phase 1/2 study of a replication-defective adenovirus encoding human platelet-derived growth factor (PDGF)-B formulated in a bovine collagen (Ad-5PDGF-B; 2.6% collagen; GAM501) gel for nonhealing neuropathic diabetic foot ulcers is
Autor:
William A. Marston, S. Lipkin, Dennis P. Orgill, I. Gordon, R.S. Hill, Peter A. Blume, J. Morgan, J.R. Hanft, Arthur Tallis, A.I. Landsman, P. Dardik
Publikováno v:
Wound Repair and Regeneration. 13:A4-A27
A novel biopolymer composed of porcine gelatin and dextran was used in a randomized controlled pilot clinical trial to treat diabetic foot ulcers to establish safety profile and evaluate effect on wound closure. Fifty-six patients were prospectively
Publikováno v:
Journal of the American Podiatric Medical Association. 102(2)
Background:There are no conclusive data to support the contention that diabetic patients have an increased frequency of ankle equinus compared with their nondiabetic counterparts. Additionally, a presumed contributing cause of foot ulceration is ankl